Summary:
«A new way to identify tumours that could be sensitive to particular immunotherapies has been developed using data from thousands of NHS cancer patient samples sequenced through the 100,000 Genomes Project. The MMRDetect clinical algorithm makes it possible to identify tumours that have ‘mismatch repair deficiencies’ and then improve the personalisation of cancer therapies to exploit those weaknesses.»
Article written by UNIVERSITY OF CAMBRIDGE
26|04|2021
Source:
EurekAlert!
https://www.eurekalert.org/pub_releases/2021-04/uoc-nca042321.php